Possible molecular mechanisms underlying age-related cardiomyocyte apoptosis in the F344XBN rat heart

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65, Issue 2, 2010, Pages 147-155

  Kakarla, Sunil K ^a   Rice, Kevin M ^b   Katta, Anjaiah ^a   Paturi, Satyanarayana ^b   Wu, Miaozong ^b   Kolli, Madhukar ^b   Keshavarzian, Saba ^b   Manzoor, Kamran ^c   Wehner, Paulette S ^a   Blough, Eric R ^a,b  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MARSHALL UNIVERSITY   (United States)

^c CHARLESTON AREA MEDICAL CENTER   (United States)

Author keywords

Aging; Apoptosis; Cardiac declines with age; Cellular senescence; Dystroglycan

Indexed keywords

RATTUS;

CASP3 PROTEIN, RAT; CASP9 PROTEIN, RAT; CASPASE 3; CASPASE 9; DYSTROGLYCAN; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; PROTEIN KINASE B;

AGING; ANIMAL; APOPTOSIS; ARTICLE; FISCHER 344 RAT; HEART MUSCLE CELL; MALE; METABOLISM; NICK END LABELING; PATHOLOGY; PHOSPHORYLATION; RAT;

AGING; ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; DYSTROGLYCANS; DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX; IN SITU NICK-END LABELING; MALE; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED F344;

EID: 75649129727     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glp203     Document Type: Article

References (46)

1. Lakatta EG. Aging and cardiovascular structure and function in healthy sedentary humans. Aging (Milano). 1998;10:162-164.
2. Hacker TA, McKiernan SH, Douglas PS, Wanagat J, Aiken JM. Age-related changes in cardiac structure and function in Fischer 344 x Brown Norway hybrid rats. Am J Physiol Heart Circ Physiol. 2006; 290:H304-H311.
3. Walker EM, Jr., Nillas MS, Mangiarua EI et al. Age-associated changes in hearts of male Fischer 344/Brown Norway F1 rats. Ann Clin Lab Sci. 2006;36:427-438.
4. Asano S, Rice KM, Kakarla S et al. Aging infl uences multiple indices of oxidative stress in the heart of the Fischer 344/NNia x Brown Nor-way/BiNia rat. Redox Rep. 2007;12:167-180. (Pubitemid 350065112)
5. Tsutsui H, Ide T, Kinugawa S. Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid Redox Signal. 2006;8:1737-1744. (Pubitemid 44726346)
6. Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res. 2004;94:1023-1031. (Pubitemid 38579696)
7. Beggs AH. Dystrophinopathy, the expanding phenotype. Dystrophin abnormalities in X-linked dilated cardiomyopathy. Circulation 1997;95:2344-2347. (Pubitemid 27224725)
8. Frank JS, Mottino G, Chen F, Peri V, Holland P, Tuana BS. Subcellular distribution of dystrophin in isolated adult and neonatal cardiac myo-cytes. Am J Physiol. 1994;267:C1707-C1716.
9. Hein S, Kostin S, Heling A, Maeno Y, Schaper J. The role of the cy-toskeleton in heart failure. Cardiovasc Res. 2000;45:273-278.
10. Keller RS, Shai SY, Babbitt CJ et al. Disruption of integrin function in the murine myocardium leads to perinatal lethality, fi brosis, and ab-normal cardiac performance. Am J Pathol. 2001;158:1079-1090.
11. Kostin S, Hein S, Arnon E, Scholz D, Schaper J. The cytoskeleton and related proteins in the human failing heart. Heart Fail Rev. 2000;5: 271-280.
12. Ortiz-Lopez R, Li H, Su J, Goytia V, Towbin JA. Evidence for a dys-trophin missense mutation as a cause of X-linked dilated cardiomyo-pathy. Circulation. 1997;95:2434-2440. (Pubitemid 27224739)
13. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystro-phin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA. 1993;90:3710-3714.
14. Wang J, Hoshijima M, Lam J et al. Cardiomyopathy associated with microcirculation dysfunction in laminin alpha4 chain-deficient mice. J Biol Chem. 2006;281:213-220. (Pubitemid 43671180)
15. Wheeler MT, Allikian MJ, Heydemann A, McNally EM. The sarco-glycan complex in striated and vascular smooth muscle. Cold Spring Harb Symp Quant Biol. 2002;67:389-397. (Pubitemid 36775535)
16. Rice KM, Preston DL, Neff D, Norton M, Blough ER. Age-related dystrophin-glycoprotein complex structure and function in the rat extensor digitorum longus and soleus muscle. J Gerontol A Biol Sci Med Sci. 2006;61:1119-1129. (Pubitemid 46034462)
17. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology. 1992;24:145-149.
18. Gupte AA, Bomhoff GL, Geiger PC. Age-related differences in skel-etal muscle insulin signaling: the role of stress kinases and heat shock proteins. J Appl Physiol. 2008;105:839-848.
19. Marzetti E, Wohlgemuth SE, Lees HA, Chung HY, Giovannini S, Leeuwenburgh C. Age-related activation of mitochondrial caspase-independent apoptotic signaling in rat gastrocnemius muscle. Mech Ageing Dev. 2008;129:542-549.
20. Wheeler MT, Zarnegar S, McNally EM. Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dys-trophy. Hum Mol Genet. 2002;11:2147-2154. (Pubitemid 34994003)
21. Costelli P, Reffo P, Penna F,Autelli R, Bonelli G, Baccino FM. Ca(2+)-dependent proteolysis in muscle wasting. Int J Biochem Cell Biol 2005;37:2134-2146.
22. Chen WS, Xu PZ, Gottlob K et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 2001;15:2203-2208. (Pubitemid 32843832)
23. Zhang Y, Herman B. Ageing and apoptosis. Mech Ageing Dev 2002;123:245-260. (Pubitemid 34024915)
24. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407: 770-776.
25. SarasteA, Pulkki K. Morphologic and biochemical hallmarks of apop-tosis. Cardiovasc Res. 2000;45:528-537.
26. Martin SJ, O'Brien GA, Nishioka WK et al. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem. 1995;270: 6425-6428.
27. Janicke RU, Ng P, Sprengart ML, Porter AG. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death sub-strates in apoptosis. J Biol Chem. 1998;273:15540-15545. (Pubitemid 28298165)
28. Vanags DM, Porn-Ares MI, Coppola S, Burgess DH, Orrenius S. Pro-tease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem. 1996;271:31075-31085. (Pubitemid 26408546)
29. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling path-way and cell survival. J Cell Mol Med. 2005;9:59-71.
30. Green AM, Steinmetz ND. Monitoring apoptosis in real time. Cancer J. 2002;8:82-92.
31. Cai J,Yang J, Jones DP. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta. 1998;1366:139-149. (Pubitemid 28467028)
32. Goldspink DF, Burniston JG, Tan LB. Cardiomyocyte death and the ageing and failing heart. Exp Physiol. 2003;88:447-458.
33. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6:99-104.
34. Kwak HB, Song W, Lawler JM. Exercise training attenuates age-induced elevation in Bax/Bcl-2 ratio, apoptosis, and remodeling in the rat heart. FASEB J. 2006;20:791-793. (Pubitemid 46671217)
35. Phaneuf S, Leeuwenburgh C. Cytochrome c release from mitochon-dria in the aging heart: a possible mechanism for apoptosis with age. Am J Physiol Regul Integr Comp Physiol. 2002;282:R423-R430. (Pubitemid 34664592)
36. Brown RH, Jr. Dystrophin-associated proteins and the muscular dys-trophies. Annu Rev Med. 1997;48:457-466.
37. Kirschner J, Bonnemann CG. The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundaries. Arch Neurol. 2004;61:189-199. (Pubitemid 38197549)
38. Malhotra SB, Hart KA, Klamut HJ et al. Frame-shift deletions in pa-tients with Duchenne and Becker muscular dystrophy. Science 1988;242:755-759.
39. Muntoni F, Cau M, Ganau A et al. Brief report: deletion of the dystro-phin muscle-promoter region associated with X-linked dilated cardio-myopathy. N Engl J Med. 1993;329:921-925. (Pubitemid 23275273)
40. Towbin JA, Bowles KR, Bowles NE. Etiologies of cardiomyopathy and heart failure. Nat Med. 1999;5:266-267.
41. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein com-plex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-823.
42. Langenbach KJ, Rando TA. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle Nerve. 2002;26:644-653.
43. Cote PD, Moukhles H, Carbonetto S. Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution. J Biol Chem. 2002;277: 4672-4679. (Pubitemid 34968497)
44. Sampaolesi M, Yoshida T, Iwata Y, Hanada H, Shigekawa M. Stretch-induced cell damage in sarcoglycan-deficient myotubes. Pfl ugers Arch. 2001;442:161-170. (Pubitemid 32476632)
45. Danialou G, Comtois AS, Dudley R et al. Dystrophin-defi cient cardio-myocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J. 2001;15:1655-1657.
46. Rando TA. Role of nitric oxide in the pathogenesis of muscular dystro-phies: a " two hit " hypothesis of the cause of muscle necrosis. Microsc Res Tech. 2001;55:223-235.